US FDA’s Eflornithine Review Is Showcase For Deep Oncology Team

 
• By Michael McCaughan

The advisory committee review of US WorldMeds’ eflornithine for neuroblastoma was remarkable for the unusual nature of the efficacy data to support the NDA – and also for who spoke on behalf of the agency and how effectively they walked the panel through a complex set of issues.

locker room shirts
FDA has many oncology team members ready to suit up for advisory committees. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers